A
Apollon develops needle-free continuous glucose monitors utilizing breakthrough Raman-based sensing technology. Their MOGLU device offers accurate, comfortable, and compact glucose monitoring comparable to existing CGMs without requiring needles. This innovation removes barriers to better diabetes care through precision, non-invasive technology.
Updated 3 months ago
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Apollon develops needle-free continuous glucose monitors utilizing breakthrough Raman-based sensing technology. Their MOGLU device offers accurate, comfortable, and compact glucose monitoring comparable to existing CGMs without requiring needles. This innovation removes barriers to better diabetes care through precision, non-invasive technology.